Base Year
Historical Year
Forecast Year
The laryngeal cancer therapeutics market size in the 7 major regions was valued at USD 4.1 billion in 2023, driven by the increasing incidence of laryngeal cancer across these regions. The market size is anticipated to grow at a CAGR of 4.20% during the forecast period of 2024-2032 to achieve a value of USD 5.9 billion by 2032.
Laryngeal cancer, which affects the voice box or larynx, presents symptoms that can often be mistaken for other conditions, making early diagnosis crucial. The most common sign is persistent hoarseness, sometimes misconstrued as a common cold symptom. If you notice ongoing symptoms such as a sore throat, chronic cough, voice changes lasting beyond two weeks, swallowing difficulties, a lump in the neck or throat, trouble producing voice sounds (dysphonia), or ear pain, it is essential to consult a healthcare provider for a proper diagnosis. Treatment for laryngeal cancer may involve surgical procedures like laryngectomy, which entails the removal of part or all the larynx. The risk of developing laryngeal cancer is significantly elevated by smoking or using tobacco products.
Significant advancements and investments in the field are significantly propelling the laryngeal cancer therapeutics market demand. One significant trend in the market is the increased investment activities. For example, an investment of over USD 11 million by the California Institute for Regenerative Medicine (CIRM) to support a phase II clinical trial aimed at testing a cell therapy for aiding throat cancer patients in their recovery from the adverse effects of radiation therapy has taken place recently. This promising initiative is conducted by Professor Peter Belafsky, an expert in otolaryngology, who also directs the UC Davis Health Center for Voice and Swallowing.
Additionally, innovative technologies are emerging to enhance the diagnosis and treatment of laryngeal cancer further influencing the laryngeal cancer therapeutics market growth. For example, a team of students, led by a lecturer in the Department of Physics at William & Mary, is developing an advanced instrument called Britescope, designed to improve endotracheal intubation procedures. Britescope's potential for success and life-saving capabilities have garnered support from the Virginia Innovation Partnership Corporation's Commonwealth Commercialization Fund. These investments and technological innovations are driving positive trends in the laryngeal cancer therapeutics market, offering new hope for patients and improving treatment outcomes.
Market Breakup by Product Type
Market Breakup by Treatment Type
Market Breakup by Route of Administration
Market Breakup by Stage
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
The market is witnessing significant growth driven by several key factors. For example, according to the latest estimates from the American Cancer Society, there are expected to be about 12,380 new cases of laryngeal cancer in the United States in 2023, indicating a rising prevalence of neck and head cancers. This surge in cases is fuelling the demand for combination therapies to effectively treat these cancers expected to contribute to the market growth.
Moreover, substantial growth in research and development activities aimed at developing innovative cancer therapeutics is also contributing to the laryngeal cancer therapeutics market growth. The increasing adoption of head and neck cancer therapeutics is also acting as a major driver, which is propelled by the urgent need for more effective treatments.
North America is currently leading the regional market due to the high number of head and neck cancers in the region. Regional market players are actively engaging in product launches, mergers, and acquisitions to establish a significant presence in the market to further boost market growth. Additionally, the presence of well-developed healthcare infrastructure and the active involvement of various government organizations in addressing the mounting burden of head and neck cancer are further propelling the regional market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Treatment Type |
|
| Breakup by Route of Administration |
|
| Breakup by Stage |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 4.1 billion in 2023, driven by increased awareness about the importance of proper treatment.
The market is anticipated to grow at a CAGR of 4.20% during the forecast period of 2024-2032 and is likely to reach a market value of USD 5.9 billion by 2032.
The increasing adoption of head and neck cancer therapeutics across the major markets is a major factor driving the market growth.
The increase in investments made by key players in the market is a major trend influencing market growth.
The major regions of the market include the United States, Japan, EU-4 and the United Kingdom. The EU-4 regions can be categorised into Germany, France, Italy, and Spain.
Various products in the market include biologics and small molecules.
Various treatments in the market include radiation therapy, chemotherapy, and immunotherapy, among others.
Various routes of administration include oral, parenteral, and topical.
Stages are as follows Stage 0, Stage-I, Stage-II, Stage-III, Stage-IV.
The end-users include hospitals, homecare, and specialty centres, among others.
Various distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
Key players involved in the market are Johnson & Johnson Private Limited, Cipla Inc., Abbott, AbbVie Inc., Merck KGaA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Amneal Pharmaceuticals LLC., Pfizer Inc., Mylan N.V., Bristol-Myers Squibb Company, GSK plc., and Hikma Pharmaceuticals PLC.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share